Jump to:
陈慧钧律师为跨国生命科学公司就一系列战略交易（包括跨境并购、股权及合作合营、风险投融资以及公开发行）提供法律咨询服务。
在加入美国瑞格律师事务所之前，陈律师曾是一家国际律师事务所波士顿总部的律师，为科技、生命科学和金融服务等领域的上市公司和私人公司提供法律咨询服务。
Experience
- Advised numerous life sciences and consumer goods companies in venture financing transactions from formation to exit and on corporate governance, intellectual property, and other ongoing commercial matters.
- Advised public companies in the life sciences and technology sectors on public company and securities compliance, including on Nasdaq and Hong Kong Stock Exchange compliance matters.
- Represented various venture capital firms investing in companies in the life sciences and consumer goods sectors in the U.S. and the Asia-Pacific region.
- Represented various multinational companies, including Johnson & Johnson and Fibrogen, in mergers, acquisitions, joint ventures and divestitures in the Asia-Pacific region.
- Advised LianBio, a company launched by life sciences investment firm Perceptive Advisors, in its formation, fundraising activities in the U.S. and China (including its $310 million crossover financing), bespoke strategic platform collaborations with Pfizer and BridgeBio and $325 million IPO of American depository shares on Nasdaq.